Veteran pharmaceutical executive to relocate to Saudi Arabia and spearhead Cipla’s growth strategy across the Middle East region
New platform integrates advanced cardiac mapping and ablation workflow, offering a novel treatment option for AFib patients at risk of stroke and heart failure
A first-of-its-kind national platform honouring the people and institutions shaping the next chapter of life sciences in India
At the center of the project is a new cosmetics line developed through collaboration between industry and medicine
Eribulin Mesylate Injection, 1 mg/2 mL (0.5 mg/mL) single-dose vials is the bioequivalent to the reference listed drug (RLD) Halaven injection of Eisai, Inc.
The transaction includes an upfront payment of $1.55 billion, along with up to $1.1 billion in regulatory and commercial milestone payments
DCGI-approved semaglutide syringes for diabetes and obesity expand treatment choices and improve affordability
The facility sets a new benchmark in respiratory diagnostics
The initiative opens pathways for female students to pursue healthcare programs across 20+ top universities and colleges in India
Acquisition provides direct access to the Dutch healthcare market, enhancing Marksans’ sales, distribution and market-access capabilities across regulated European markets
Subscribe To Our Newsletter & Stay Updated
